BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21221591)

  • 1. Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India.
    Singh S; Chandrakasan S; Ahluwalia J; Suri D; Rawat A; Ahmed N; Das R; Sachdeva MU; Varma N
    Rheumatol Int; 2012 Apr; 32(4):881-6. PubMed ID: 21221591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis.
    Zeng HS; Xiong XY; Wei YD; Wang HW; Luo XP
    World J Pediatr; 2008 May; 4(2):97-101. PubMed ID: 18661762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: analysis of 13 patients].
    Shi H; Wang HW; Cheng PX; Hu XF; Liu QJ; Wan LJ
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):812-7. PubMed ID: 17274866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.
    Reddy VV; Myles A; Cheekatla SS; Singh S; Aggarwal A
    Int J Rheum Dis; 2014 Mar; 17(3):261-7. PubMed ID: 24417800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Macrophage activation syndrome in Chinese children with systemic onset juvenile idiopathic arthritis].
    Li CF; He XH; Kuang WY; Han TX; Zhou YF
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):806-11. PubMed ID: 17274865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.
    Minoia F; Davì S; Horne A; Demirkaya E; Bovis F; Li C; Lehmberg K; Weitzman S; Insalaco A; Wouters C; Shenoi S; Espada G; Ozen S; Anton J; Khubchandani R; Russo R; Pal P; Kasapcopur O; Miettunen P; Maritsi D; Merino R; Shakoory B; Alessio M; Chasnyk V; Sanner H; Gao YJ; Huasong Z; Kitoh T; Avcin T; Fischbach M; Frosch M; Grom A; Huber A; Jelusic M; Sawhney S; Uziel Y; Ruperto N; Martini A; Cron RQ; Ravelli A; ; ; ;
    Arthritis Rheumatol; 2014 Nov; 66(11):3160-9. PubMed ID: 25077692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic-onset juvenile idiopathic arthritis.
    Cimaz R
    Autoimmun Rev; 2016 Sep; 15(9):931-4. PubMed ID: 27392503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage activation syndrome in pediatrics: 10 years data from an Indian center.
    Pal P; Bathia J; Giri PP; Roy M; Nandi A
    Int J Rheum Dis; 2020 Oct; 23(10):1412-1416. PubMed ID: 32666639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
    Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
    Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage activation syndrome in children with Kawasaki disease: an experience from a tertiary care hospital in northwest India.
    Pilania RK; Jindal AK; Johnson N; Prithvi A; Vignesh P; Suri D; Rawat A; Gupta A; Singh S
    Rheumatology (Oxford); 2021 Jul; 60(7):3413-3419. PubMed ID: 33221920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage activation syndrome in an inadequately treated patient with systemic onset juvenile idiopathic arthritis.
    Juneja M; Jain R; Mishra D
    Kathmandu Univ Med J (KUMJ); 2009; 7(28):411-3. PubMed ID: 20502084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Shimizu M; Mizuta M; Okamoto N; Yasumi T; Iwata N; Umebayashi H; Okura Y; Kinjo N; Kubota T; Nakagishi Y; Nishimura K; Mohri M; Yashiro M; Yasumura J; Wakiguchi H; Mori M
    Pediatr Rheumatol Online J; 2020 Jan; 18(1):2. PubMed ID: 31924225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic onset juvenile idiopathic arthritis: a single center experience.
    Sağ E; Uzunoğlu B; Bal F; Sönmez HE; Demir S; Bilginer Y; Özen S
    Turk J Pediatr; 2019; 61(6):852-858. PubMed ID: 32134578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases.
    Lin CI; Yu HH; Lee JH; Wang LC; Lin YT; Yang YH; Chiang BL
    Clin Rheumatol; 2012 Aug; 31(8):1223-30. PubMed ID: 22615046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Macrophage activation syndrome associated with systemic juvenile idiopathic arthritis].
    Silva CA; Silva CH; Robazzi TC; Lotito AP; Mendroni Junior A; Jacob CM; Kiss MH
    J Pediatr (Rio J); 2004; 80(6):517-22. PubMed ID: 15622430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult macrophage activation syndrome in systemic-onset juvenile idiopathic arthritic syndrome--a case report.
    Zeng P; Li F; Zeng H
    Acta Reumatol Port; 2013; 38(3):196-200. PubMed ID: 24149017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic plasma exchange in refractory macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a case-based review.
    Liquidano-Perez E; Maza-Ramos G; Salazar-Bailón JL; Yamazaki-Nakashimada MA; Rivas-Larrauri F
    Rheumatol Int; 2023 Jan; 43(1):183-189. PubMed ID: 36264324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.
    Schulert GS; Minoia F; Bohnsack J; Cron RQ; Hashad S; KonÉ-Paut I; Kostik M; Lovell D; Maritsi D; Nigrovic PA; Pal P; Ravelli A; Shimizu M; Stanevicha V; Vastert S; Woerner A; de Benedetti F; Grom AA
    Arthritis Care Res (Hoboken); 2018 Mar; 70(3):409-419. PubMed ID: 28499329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of macrophage activation syndrome in children with rheumatic disorders.
    Moradinejad MH; Ziaee V
    Minerva Pediatr; 2011 Dec; 63(6):459-66. PubMed ID: 22075800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anakinra and hepatotoxicity in pediatric rheumatology: a case series.
    Martins FR; Azevedo AC; Ganhão S; Aguiar F; Rodrigues M; Brito I
    Pediatr Rheumatol Online J; 2023 Oct; 21(1):112. PubMed ID: 37803456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.